한빛사논문
Faheem Ahmed 1, In Suk Kang 1, Kyung Hwan Kim 2, Arun Asif 3, Chethikkattuveli Salih Abdul Rahim 1, Anupama Samantasinghar 1, Fida Hussain Memon 1,4, Kyung Hyun Choi 1
1Department of Mechatronics Engineering, Jeju National University, Jeju, South Korea.
2BioSpero, Inc., Jeju, Jeju-do, South Korea.
3Department of Microbiology and Immunology, College of Dental Medicine, Columbia University, New York City, New York, USA.
4Department of Electrical Engineering, Sukkur IBA University, Sukkur, Pakistan.
Correspondence Kyung Hyun Choi
Abstract
Cancer management is major concern of health organizations and viral cancers account for approximately 15.4% of all known human cancers. Due to large number of patients, efficient treatments for viral cancers are needed. De novo drug discovery is time consuming and expensive process with high failure rate in clinical stages. To address this problem and provide treatments to patients suffering from viral cancers faster, drug repurposing emerges as an effective alternative which aims to find the other indications of the Food and Drug Administration approved drugs. Applied to viral cancers, drug repurposing studies following the niche have tried to find if already existing drugs could be used to treat viral cancers. Multiple drug repurposing approaches till date have been introduced with successful results in viral cancers and many drugs have been successfully repurposed various viral cancers. Here in this study, a critical review of viral cancer related databases, tools, and different machine learning, deep learning and virtual screening-based drug repurposing studies focusing on viral cancers is provided. Additionally, the mechanism of viral cancers is presented along with drug repurposing case study specific to each viral cancer. Finally, the limitations and challenges of various approaches along with possible solutions are provided.
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기